These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 24887492)

  • 1. Human umbilical cord-derived mesenchymal stem cells do not undergo malignant transformation during long-term culturing in serum-free medium.
    Chen G; Yue A; Ruan Z; Yin Y; Wang R; Ren Y; Zhu L
    PLoS One; 2014; 9(6):e98565. PubMed ID: 24887492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [SOX9 enhanced chondrogenic differentiation potential of human umbilical cord mesenchymal stem cells through cellular aggregation].
    Xu Y; Chen L; Shi Y; Gu Y; Zou J; Huang C; Tang TS
    Zhonghua Yi Xue Za Zhi; 2012 Aug; 92(29):2050-4. PubMed ID: 23253807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Capacity of human umbilical cord-derived mesenchymal stem cells to differentiate into sweat gland-like cells: a preclinical study.
    Yang S; Ma K; Feng C; Wu Y; Wang Y; Huang S; Fu X
    Front Med; 2013 Sep; 7(3):345-53. PubMed ID: 23794058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monitoring the biology stability of human umbilical cord-derived mesenchymal stem cells during long-term culture in serum-free medium.
    Chen G; Yue A; Ruan Z; Yin Y; Wang R; Ren Y; Zhu L
    Cell Tissue Bank; 2014 Dec; 15(4):513-21. PubMed ID: 24407613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigating the differential therapeutic efficacy and mechanisms of human umbilical cord mesenchymal stem cells at various passages in osteoarthritis treatment.
    Zhang Y; He X; Ge Z; Wang B; Ni M; Cai G
    Tissue Cell; 2024 Oct; 90():102499. PubMed ID: 39126832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the impact of customized serum-free culture medium on the production of clinical-grade human umbilical cord mesenchymal stem cells: insights for future clinical applications.
    Zhao L; Ni B; Li J; Liu R; Zhang Q; Zheng Z; Yang W; Yu W; Bi L
    Stem Cell Res Ther; 2024 Sep; 15(1):327. PubMed ID: 39334391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolation and proliferation of umbilical cord tissue derived mesenchymal stem cells for clinical applications.
    Van Pham P; Truong NC; Le PT; Tran TD; Vu NB; Bui KH; Phan NK
    Cell Tissue Bank; 2016 Jun; 17(2):289-302. PubMed ID: 26679929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study of the biological characteristics of human umbilical cord mesenchymal stem cells after long-time cryopreservation.
    Zhang M; Zhao Y; Wang L; Zheng Y; Yu H; Dong X; He W; Yin Z; Wang Z
    Cell Tissue Bank; 2022 Dec; 23(4):739-752. PubMed ID: 35066739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Equine mesenchymal stem cells from bone marrow, adipose tissue and umbilical cord: immunophenotypic characterization and differentiation potential.
    Barberini DJ; Freitas NP; Magnoni MS; Maia L; Listoni AJ; Heckler MC; Sudano MJ; Golim MA; da Cruz Landim-Alvarenga F; Amorim RM
    Stem Cell Res Ther; 2014 Feb; 5(1):25. PubMed ID: 24559797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparison of the biological characteristics of serum-free and fetal bovine serum-contained medium cultured umbilical cord-derived mesenchymal stem cells].
    Yang T; Chen GH; Xue SL; Qiao M; Liu HW; Tian H; Qiao SM; Chen F; Chen ZZ; Sun AN; Wu DP
    Zhonghua Xue Ye Xue Za Zhi; 2012 Sep; 33(9):715-9. PubMed ID: 23336223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subarachnoid transplantation of human umbilical cord mesenchymal stem cell in rodent model with subacute incomplete spinal cord injury: Preclinical safety and efficacy study.
    Yang Y; Cao TT; Tian ZM; Gao H; Wen HQ; Pang M; He WJ; Wang NX; Chen YY; Wang Y; Li H; Lin JW; Kang Z; Li MM; Liu B; Rong LM
    Exp Cell Res; 2020 Oct; 395(2):112184. PubMed ID: 32707134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum-free human MSC medium supports consistency in human but not in equine adipose-derived multipotent mesenchymal stromal cell culture.
    Schubert S; Brehm W; Hillmann A; Burk J
    Cytometry A; 2018 Jan; 93(1):60-72. PubMed ID: 28926198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A critical appraisal of humanized alternatives to fetal bovine serum for clinical applications of umbilical cord derived mesenchymal stromal cells.
    Rallapalli S; Guhathakurta S; Bishi DK; Subbarayan R; Mathapati S; Korrapati PS
    Biotechnol Lett; 2021 Oct; 43(10):2067-2083. PubMed ID: 34499291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [IL-1β inhibits macrophage M2 polarization by down-regulating CD200 expression in human umbilical cord mesenchymal stem cells].
    Zhu Y; Li L; Wang Z; Tan X; Tao J; Ding L; Dong H; Ye P
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2024 Mar; 40(3):193-198. PubMed ID: 38512028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pooled Umbilical Cord Blood Plasma for Culturing UCMSC and Ex Vivo Expanding Umbilical Cord Blood CD34⁺ Cells].
    Wu JY; Lu Y; Chen JS; Wu SQ; Tang XW; Li Y
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Aug; 23(4):1112-9. PubMed ID: 26314456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and characterization of a clinically compliant xeno-free culture medium in good manufacturing practice for human multipotent mesenchymal stem cells.
    Chase LG; Yang S; Zachar V; Yang Z; Lakshmipathy U; Bradford J; Boucher SE; Vemuri MC
    Stem Cells Transl Med; 2012 Oct; 1(10):750-8. PubMed ID: 23197667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human mesenchymal stem cells possess different biological characteristics but do not change their therapeutic potential when cultured in serum free medium.
    Wang Y; Wu H; Yang Z; Chi Y; Meng L; Mao A; Yan S; Hu S; Zhang J; Zhang Y; Yu W; Ma Y; Li T; Cheng Y; Wang Y; Wang S; Liu J; Han J; Li C; Liu L; Xu J; Han ZB; Han ZC
    Stem Cell Res Ther; 2014 Dec; 5(6):132. PubMed ID: 25476802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancement of angiogenic effects by hypoxia-preconditioned human umbilical cord-derived mesenchymal stem cells in a mouse model of hindlimb ischemia.
    Han KH; Kim AK; Kim MH; Kim DH; Go HN; Kim DI
    Cell Biol Int; 2016 Jan; 40(1):27-35. PubMed ID: 26222206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mesenchymal stem cells from CD34(-) human umbilical cord blood.
    Lu X; Alshemali S; de Wynter EA; Dickinson AM
    Transfus Med; 2010 Jun; 20(3):178-84. PubMed ID: 19948008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenotype Characteristics and Osteogenic Differentiation Potential of Human Mesenchymal Stem Cells Derived from Amnion Membrane (HAMSCs) and Umbilical Cord (HUC-MSCs).
    Hendrijantini N; Hartono P
    Acta Inform Med; 2019 Jun; 27(2):72-77. PubMed ID: 31452562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.